Endocrinology News and Research

Latest Endocrinology News and Research

Empagliflozin drug reduces blood pressure in patients with Type 2 diabetes, hypertension

An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds. The results were presented Sunday in a late-breaking abstract at the joint meeting of the International Society of Endocrinology and The Endocrine Society: ICE/ENDO 2014 in Chicago.

23 Jun 2014

Research roundup: Improving colon cancer screening; disparities in heart care; Medicaid expansion's effect on cities

This report estimated the effect of the Affordable Care Act (ACA) on 14 large and diverse cities: Los Angeles, Chicago, Houston, Philadelphia, Phoenix, Indianapolis, Columbus, Charlotte, Detroit, Memphis, Seattle, Denver, Atlanta, and Miami.

21 Jun 2014

Greenlander study identifies single mutation with large diabetes risk

Researchers have used a Greenlandic cohort to identify a genetic mutation whose effect on the risk of diabetes is “several times larger” than any previously discovered.

20 Jun 2014

Continuation of metformin after cirrhosis diagnosis improves survival rates in diabetes patients

Researchers at Mayo Clinic released a new study reversing current thought on the treatment of cirrhotic patients with type 2 diabetes.

20 Jun 2014

Scientists create bone material from human stem cells to improve patient's welfare

Bone defects, like a damaged femoral head, are usually replaced by metal implants. This has many disadvantages, but now scientists in Germany have created bone material from human stem cells that could bring significant improvement to the patient's welfare.

20 Jun 2014

New research reveals gene's role in type 1 diabetes

New research describes details of how a diabetes-related gene functions on a biological pathway that affects the release of insulin. The study authors say that finding drugs that act on that pathway may eventually lead to a new treatment for type 1 diabetes.

20 Jun 2014

Susceptibility gene for type 1 diabetes regulates self-destruction of cell's energy factory

A team led by researchers from the Perelman School of Medicine at the University of Pennsylvania found that a susceptibility gene for type 1 diabetes regulates self-destruction of the cell's energy factory. They report their findings this week in Cell.

20 Jun 2014

Experts urge business to track worker health

A new group is urging businesses to improve the health of employees -- and says the move could save up to $30 billion a year in health care costs.

20 Jun 2014

Research provides unique insight into lncRNAs that regulate lung development

It's a long way from DNA to RNA to protein, and only about two percent of a person's genome is eventually converted into proteins.

19 Jun 2014

First Edition: June 19, 2014

Today's headlines include reports about how the 2015 insurance premium rates are shaping up across the country and details of consumers' experiences in trying to get their new coverage.

19 Jun 2014

Detective work maps special gene variant among Greenlanders which plays role in type 2 diabetes

A spectacular piece of detective work has mapped a special gene variant among Greenlanders which plays a particularly important role in the development of type 2 diabetes.

19 Jun 2014

Study of SLC13 transporters unlocks their therapeutic potential

Researchers have provided the first functional analysis of a member of a family of transporter proteins implicated in diabetes, obesity, and lifespan. The study appears in the June issue of The Journal of General Physiology.

19 Jun 2014

Apitope starts preclinical development of ATX-GD-459 for Graves' disease treatment

Apitope, the drug discovery and development company focused on disease-modifying treatments for patients with autoimmune and allergic diseases, announced today that it has started preclinical development of its novel peptide therapy ATX-GD-459 for the treatment of Graves' disease.

19 Jun 2014

State highlights: Illinois Medicaid digital shift delayed; N.C. hospitals fight cuts; heroin in New England

Alexian Brothers Health System is suspending its effort to launch a new Medicaid program, blaming the difficulty of connecting physicians using different electronic records systems. The Arlington Heights, Ill.-based health system was spearheading a so-called accountable care entity (ACE) to coordinate the care of about 46,000 patients on Medicaid, the state-federal health insurance program for the poor and disabled. The ACEs are a form of managed care, one of Gov. Pat Quinn's initiatives to focus on preventative treatment to keep patients healthy and reduce health care costs (Schorsch, 6/17).

19 Jun 2014

Mayo Clinic study: Reversing current thought on treatment of cirrhotic patients with type 2 diabetes

Researchers at Mayo Clinic released a new study reversing current thought on the treatment of cirrhotic patients with type 2 diabetes. The study found that the continuation of metformin after a cirrhosis diagnosis improved survival rates among diabetes patients.

19 Jun 2014

UC Irvine Health to use $3.4 million NIH grant to examine "Transition of Care in CKD"

UC Irvine Health will use a $3.4 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health to examine the "Transition of Care in Chronic Kidney Disease (CKD)."

19 Jun 2014

Healthy inflammation necessary to prevent metabolic diseases, study finds

Chronic tissue inflammation is typically associated with obesity and metabolic disease, but new research from UT-Southwestern Medical Center now finds that a level of "healthy" inflammation is necessary to prevent metabolic diseases, such as fatty liver.

19 Jun 2014

U of MD researchers to use $3.7 million NIH grant to develop novel method to treat monogenic diabetes

The National Institutes of Health has awarded a four-year, $3.7 million grant to researchers at the University of Maryland School of Medicine to develop a personalized medicine program to help doctors diagnose and treat monogenic diabetes - a form of diabetes caused by a mutation in a single gene.

19 Jun 2014

Counseling, medication management by pharmacist can lower hospital readmissions

Getting discharged from the hospital and then having to go right back in again can be emotionally draining for a patient and their family. It can also cause financial strain for all involved - the patient, the hospital system and the insurers-including Medicaid and Medicare, which are taxpayer funded.

19 Jun 2014

Joslin and CSHI partner to develop online "virtual" case based interactive educational materials

Joslin Diabetes Center and Carlos Slim Health Institute (CSHI) announced they have created a partnership to develop a series of online "virtual" case based interactive educational materials for primary care physicians in Mexico. The educational materials will cover topics such as, prevention and treatment of type 2 diabetes as well as its complications and co-morbidities.

18 Jun 2014

Endocrinology News and Research

Latest Endocrinology News and Research

Empagliflozin drug reduces blood pressure in patients with Type 2 diabetes, hypertension

Research roundup: Improving colon cancer screening; disparities in heart care; Medicaid expansion's effect on cities

Greenlander study identifies single mutation with large diabetes risk

Continuation of metformin after cirrhosis diagnosis improves survival rates in diabetes patients

Scientists create bone material from human stem cells to improve patient's welfare

New research reveals gene's role in type 1 diabetes

Susceptibility gene for type 1 diabetes regulates self-destruction of cell's energy factory

Experts urge business to track worker health

Research provides unique insight into lncRNAs that regulate lung development

First Edition: June 19, 2014

Detective work maps special gene variant among Greenlanders which plays role in type 2 diabetes

Study of SLC13 transporters unlocks their therapeutic potential

Apitope starts preclinical development of ATX-GD-459 for Graves' disease treatment

State highlights: Illinois Medicaid digital shift delayed; N.C. hospitals fight cuts; heroin in New England

Mayo Clinic study: Reversing current thought on treatment of cirrhotic patients with type 2 diabetes

UC Irvine Health to use $3.4 million NIH grant to examine "Transition of Care in CKD"

Healthy inflammation necessary to prevent metabolic diseases, study finds

U of MD researchers to use $3.7 million NIH grant to develop novel method to treat monogenic diabetes

Counseling, medication management by pharmacist can lower hospital readmissions

Joslin and CSHI partner to develop online "virtual" case based interactive educational materials

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Endocrinology News and Research

Latest Endocrinology News and Research

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Newsletters you may be interested in